Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine

DSpace/Manakin Repository

Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine

Citable link to this page

. . . . . .

Title: Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine
Author: Greilsamer, Glenn J.
Citation: Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine (2002 Third Year Paper)
Full Text & Related Files:
Abstract: This paper explores the various impediments to the development of a safe and effective AIDS vaccine, and offers suggestions to help overcome these obstacles. I begin by discussing the FDA approval process and the current state of AIDS vaccine development. I then consider the different scientific impediments to the development of a preventive vaccine. The next section addresses the logistical and ethical issues in the clinical testing of a vaccine. I discuss the ethical principles that should guide researchers, demonstrate the social harm that participation may cause volunteers, and suggest methods to resolve these ethical dilemmas. Finally, I discuss the economic impediments faced by manufacturers in the form of high costs, uncertain profit margins, and unpredictable liability. Using past legislative attempts at restructuring manufacturer incentives as models, I present recommendations to help encourage manufacturers to produce the safest and most effective vaccine they can, and make it available as quickly as possible.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852124

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters